Oaktree Capital Management’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-135,000
Closed -$1.48M 182
2023
Q4
$1.48M Hold
135,000
0.02% 170
2023
Q3
$1.45M Hold
135,000
0.02% 188
2023
Q2
$1.42M Hold
135,000
0.02% 214
2023
Q1
$1.4M Hold
135,000
0.02% 262
2022
Q4
$1.37M Buy
+135,000
New +$1.37M 0.01% 298